Advanced Therapies in Belgium

15 Oct 2024 | Namur, Belgium

Tuesday, 15 October 2024 | 11:40 - 12:30

Panel - Overcoming bottlenecks in the advanced therapy supply chain: company and hospital perspectives

Format:In-person
90 participants

Hugues Wallemacq (CEO, Exo Biologics), Laeticia Malphettes (Head of Gene Therapy Process and Analytical Sciences, UCB), Bernard Piette (Managing Director Logistics in Wallonia), Samuel Speltdoorn (Senior Business & Network Development Manager Cargo at Brussels Airport Company), Koen Debackere (dr., UZ Leuven)

Moderator: Pieter Sauwens, Director, Monitor Deloitte

This panel will feature an in-depth exploration of the strengths and challenges within the Belgium ecosystem for manufacturing and supply chain of Advanced Therapies. Industry experts will share insights on key strengths and assets in the Belgian ecosystem, while also addressing the challenges such as fostering innovation, cost-effectiveness, and reimbursements. This perspective will be complimented by the challenges and opportunities hospitals are experiencing in bringing advanced therapies to patients, including new European legislation. The event will also highlight the contributions of industry and government organisations in alleviating industry challenges. This promises to be a thought-provoking and insightful event for all ecosystem players.

1 speaker